Equine asthma: Recognizing and managing respiratory issues in horses
Equine asthma: Recognizing and managing respiratory issues in horses
Search
Science Focus
Science and Innovation - Human Health Innovation - Science Focus
Vaccines
Science and Innovation - Animal Health Innovation - Vaccines
Global Careers Page
Join a global team of more than 52,000 passionate and talented individuals dedicated to improving the health of humans and animals worldwide.
The Research Process
Science and Innovation - Animal Health Innovation - Parasiticides
Lung Cancer
Lung Cancer
Livestock
Livestock
Boehringer Ingelheim increases commitments to sustainable development
Boehringer Ingelheim increases commitments to sustainable development
Boehringer Ingelheim’s latest investigational treatment slowed lung function decline in people living with idiopathic pulmonary fibrosis
Promising 12-week Phase II trial data with BI 1015550, a novel investigational phosphodiesterase 4B (PDE4B) inhibitor, published in The New England Journal of Medicine Potential new treatment for progressive pulmonary fibrosis (PPF) builds on Boehringer
Parasiticides
Science and Innovation - Animal Health Innovation - Parasiticides
Equine
Equine
GPP
GPP
Pulmonary Fibrosis
Pulmonary Fibrosis
Patient Centricity
Patient Centricity
Across Cancer Types
Across Cancer Types
Our Responsibility
Our Responsibility
Bovine
Bovine
University Health Network and Boehringer Ingelheim Canada partner to impact patients lives and help a healthcare system under strain
University Health Network and Boehringer Ingelheim Canada partner to impact patients lives and help a healthcare system under strain
Sunnybrook collaborates with Boehringer Ingelheim Canada to enhance care for complex cardiovascular patients
Sunnybrook collaborates with Boehringer Ingelheim Canada to enhance care for complex cardiovascular patients
Boehringer Ingelheim Canada and community-based clinics join to revolutionize cardiovascular care in Ontario
Boehringer Ingelheim Canada and community-based clinics join to revolutionize cardiovascular care in Ontario
Pets
Pets
New collaboration to improve the detection of type 2 diabetes in high-risk patients starts in Montreal, Quebec
The project will use artificial intelligence (A.I.), wearable technologies and electronic health record systems to identify patients who may have type 2 diabetes in Montreal, Quebec
First half of 2024: Boehringer Ingelheim progresses pipeline at pace and reaches major milestones
First half of 2024: Boehringer Ingelheim progresses pipeline at pace and reaches major milestones
Good business performance gives Boehringer Ingelheim tailwind for investment in R&D
R&D investment up 11.7% to 4.1 billion EUR in 2021 (20.0% of net sales) More than 25 billion EUR investment in R&D and 7 billion EUR in capital expenditure over the next five years Human Pharma pipeline acceleration: up to 15 new product launches
Helping patients by addressing health system gaps
Helping patients by addressing health system gaps